PAINCHEK Stock Australian S.E.

PainChek Limited is an Australia-based company which develops pain assessment technologies. The Company's principal activities are development and commercialization of mobile medical device applications that provide pain assessment for individuals that are unable to communicate with their carers. Its segments include Infant App (in Australia), and Adult App in Australia and New Zealand (ANZ), the United Kingdom (UK) and North America. The Company's PainChek Universal is a complete point-of-care solution that combines the existing PainChek Application with the numerical rating scale (NRS). PainChek Application uses artificial intelligence and facial recognition to detect pain in those who cannot self-report. This gives a voice to those who cannot verbalize pain, whilst also driving objectivity and consistency in all assessments. PainChek Universal also supports pain assessment using both tools at the point of care, for those people whose ability to communicate fluctuates.